back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-01-24 13:30 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,438
+5,000 vol $1.09 each |
11,515 | |
| Filed 2021-10-20 15:49 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,000
+60,000 vol $1.40 each |
150,303 | |
| Filed 2021-09-29 22:07 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,840
+5,000 vol $1.77 each |
6,515 | |
| Filed 2021-09-29 22:06 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,840
+5,000 vol $1.77 each |
||
| Filed 2020-12-18 14:20 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,000
+60,000 vol $3.85 each |
90,303 | |
| Filed 2020-12-18 14:16 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-969,697 vol |
30,303 | |
| Filed 2020-12-03 15:18 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-48,485 vol |
1,515 | |
| Filed 2019-10-25 20:00 Tx date 2019-10-24 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+5,000 vol $0.27 each |
50,000 | |
| Filed 2019-10-11 17:34 Tx date 2019-10-11 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,290
+5,000 vol $0.258 each |
45,000 | |
| Filed 2019-10-11 17:33 Tx date 2019-10-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,680
+10,000 vol $0.268 each |
40,000 | |
| Filed 2019-10-04 12:46 Tx date 2019-10-03 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+5,000 vol $0.28 each |
30,000 | |
| Filed 2019-10-01 13:51 Tx date 2019-08-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2019-08-16 18:57 Tx date 2019-08-09 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2016-01-11 Tx date 2016-01-04 |
$ETG
Entree Gold Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-694,000
-200,000 vol $3.47 each |
1,175,000 | |
| Filed 2015-12-08 Tx date 2015-12-04 |
$ETG
Entree Gold Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,250
+125,000 vol $0.33 each |
1,375,000 |